nodes	percent_of_prediction	percent_of_DWPC	metapath
Verapamil—ABCG2—Topotecan—cervical cancer	0.455	0.634	CbGbCtD
Verapamil—ABCB1—Topotecan—cervical cancer	0.164	0.229	CbGbCtD
Verapamil—CYP3A4—Topotecan—cervical cancer	0.0984	0.137	CbGbCtD
Verapamil—CACNA1G—decidua—cervical cancer	0.00592	0.0228	CbGeAlD
Verapamil—CACNB3—uterine cervix—cervical cancer	0.00572	0.022	CbGeAlD
Verapamil—CACNB3—decidua—cervical cancer	0.00545	0.0209	CbGeAlD
Verapamil—CACNB3—endometrium—cervical cancer	0.00517	0.0199	CbGeAlD
Verapamil—CACNB4—vagina—cervical cancer	0.00506	0.0194	CbGeAlD
Verapamil—CACNB3—mammalian vulva—cervical cancer	0.005	0.0192	CbGeAlD
Verapamil—CACNB3—uterus—cervical cancer	0.00477	0.0183	CbGeAlD
Verapamil—CYP2C18—uterine cervix—cervical cancer	0.00456	0.0175	CbGeAlD
Verapamil—CACNB3—female reproductive system—cervical cancer	0.00428	0.0165	CbGeAlD
Verapamil—CACNB1—female gonad—cervical cancer	0.00406	0.0156	CbGeAlD
Verapamil—CYP2C18—mammalian vulva—cervical cancer	0.00399	0.0153	CbGeAlD
Verapamil—CACNA1I—lymph node—cervical cancer	0.00398	0.0153	CbGeAlD
Verapamil—CACNB3—female gonad—cervical cancer	0.0039	0.015	CbGeAlD
Verapamil—CACNB3—vagina—cervical cancer	0.00387	0.0149	CbGeAlD
Verapamil—CACNA1H—uterus—cervical cancer	0.00339	0.013	CbGeAlD
Verapamil—CACNA1D—uterine cervix—cervical cancer	0.00336	0.0129	CbGeAlD
Verapamil—CYP2C18—vagina—cervical cancer	0.00309	0.0119	CbGeAlD
Verapamil—CACNA1B—lymph node—cervical cancer	0.00305	0.0117	CbGeAlD
Verapamil—CACNA1H—female reproductive system—cervical cancer	0.00305	0.0117	CbGeAlD
Verapamil—CACNA1C—decidua—cervical cancer	0.00295	0.0113	CbGeAlD
Verapamil—ABCC10—uterine cervix—cervical cancer	0.00281	0.0108	CbGeAlD
Verapamil—SLCO1B1—renal system—cervical cancer	0.00278	0.0107	CbGeAlD
Verapamil—CACNA1H—female gonad—cervical cancer	0.00277	0.0107	CbGeAlD
Verapamil—KCNJ11—female reproductive system—cervical cancer	0.00273	0.0105	CbGeAlD
Verapamil—ABCC3—decidua—cervical cancer	0.00269	0.0103	CbGeAlD
Verapamil—ABCC10—decidua—cervical cancer	0.00267	0.0103	CbGeAlD
Verapamil—ABCC3—renal system—cervical cancer	0.00264	0.0101	CbGeAlD
Verapamil—ABCC10—renal system—cervical cancer	0.00263	0.0101	CbGeAlD
Verapamil—CACNB1—lymph node—cervical cancer	0.00261	0.01	CbGeAlD
Verapamil—CACNB2—vagina—cervical cancer	0.0026	0.01	CbGeAlD
Verapamil—ABCC10—endometrium—cervical cancer	0.00254	0.00975	CbGeAlD
Verapamil—SLC22A4—decidua—cervical cancer	0.00251	0.00965	CbGeAlD
Verapamil—CACNB3—lymph node—cervical cancer	0.00251	0.00962	CbGeAlD
Verapamil—KCNJ11—female gonad—cervical cancer	0.00249	0.00954	CbGeAlD
Verapamil—SLC22A4—renal system—cervical cancer	0.00247	0.00948	CbGeAlD
Verapamil—ABCC10—mammalian vulva—cervical cancer	0.00246	0.00943	CbGeAlD
Verapamil—SLC22A4—endometrium—cervical cancer	0.00239	0.00916	CbGeAlD
Verapamil—SLC22A1—renal system—cervical cancer	0.00235	0.00902	CbGeAlD
Verapamil—ABCC10—uterus—cervical cancer	0.00234	0.00898	CbGeAlD
Verapamil—CACNA1C—female reproductive system—cervical cancer	0.00232	0.00892	CbGeAlD
Verapamil—SLCO1A2—renal system—cervical cancer	0.00226	0.00869	CbGeAlD
Verapamil—SLCO1B1—female reproductive system—cervical cancer	0.00223	0.00855	CbGeAlD
Verapamil—ABCC4—renal system—cervical cancer	0.00218	0.00836	CbGeAlD
Verapamil—ABCC3—female reproductive system—cervical cancer	0.00211	0.00811	CbGeAlD
Verapamil—ABCC2—renal system—cervical cancer	0.00211	0.00809	CbGeAlD
Verapamil—ABCC10—female reproductive system—cervical cancer	0.0021	0.00807	CbGeAlD
Verapamil—CACNA1C—vagina—cervical cancer	0.0021	0.00807	CbGeAlD
Verapamil—SCN5A—vagina—cervical cancer	0.00204	0.00782	CbGeAlD
Verapamil—ABCC1—uterine cervix—cervical cancer	0.00198	0.00762	CbGeAlD
Verapamil—SLC22A4—female reproductive system—cervical cancer	0.00198	0.00759	CbGeAlD
Verapamil—ABCC4—uterus—cervical cancer	0.00194	0.00745	CbGeAlD
Verapamil—ABCC3—female gonad—cervical cancer	0.00192	0.00738	CbGeAlD
Verapamil—ABCC10—female gonad—cervical cancer	0.00191	0.00735	CbGeAlD
Verapamil—ABCC10—vagina—cervical cancer	0.0019	0.0073	CbGeAlD
Verapamil—ABCC1—decidua—cervical cancer	0.00189	0.00726	CbGeAlD
Verapamil—KCNH2—uterine cervix—cervical cancer	0.00185	0.00709	CbGeAlD
Verapamil—ABCC1—endometrium—cervical cancer	0.0018	0.00689	CbGeAlD
Verapamil—SLC22A4—vagina—cervical cancer	0.00179	0.00686	CbGeAlD
Verapamil—CACNA1H—lymph node—cervical cancer	0.00178	0.00685	CbGeAlD
Verapamil—SLC6A4—female reproductive system—cervical cancer	0.00175	0.00672	CbGeAlD
Verapamil—SLC22A5—uterine cervix—cervical cancer	0.00175	0.0067	CbGeAlD
Verapamil—ABCC4—female reproductive system—cervical cancer	0.00174	0.0067	CbGeAlD
Verapamil—ABCC1—mammalian vulva—cervical cancer	0.00174	0.00667	CbGeAlD
Verapamil—KCNH2—renal system—cervical cancer	0.00173	0.00664	CbGeAlD
Verapamil—SLC22A1—vagina—cervical cancer	0.0017	0.00654	CbGeAlD
Verapamil—ABCC2—female reproductive system—cervical cancer	0.00169	0.00648	CbGeAlD
Verapamil—CACNB2—lymph node—cervical cancer	0.00168	0.00647	CbGeAlD
Verapamil—KCNH2—endometrium—cervical cancer	0.00167	0.00641	CbGeAlD
Verapamil—ABCC1—uterus—cervical cancer	0.00165	0.00635	CbGeAlD
Verapamil—ABCG2—uterine cervix—cervical cancer	0.00164	0.00631	CbGeAlD
Verapamil—SLC22A5—renal system—cervical cancer	0.00163	0.00627	CbGeAlD
Verapamil—KCNJ11—lymph node—cervical cancer	0.0016	0.00614	CbGeAlD
Verapamil—ABCC4—female gonad—cervical cancer	0.00159	0.00609	CbGeAlD
Verapamil—CYP2C8—renal system—cervical cancer	0.00158	0.00607	CbGeAlD
Verapamil—SLC22A5—endometrium—cervical cancer	0.00158	0.00606	CbGeAlD
Verapamil—ABCG2—decidua—cervical cancer	0.00157	0.00601	CbGeAlD
Verapamil—KCNH2—uterus—cervical cancer	0.00154	0.00591	CbGeAlD
Verapamil—CYP2C8—endometrium—cervical cancer	0.00153	0.00587	CbGeAlD
Verapamil—CYP3A5—uterine cervix—cervical cancer	0.00153	0.00586	CbGeAlD
Verapamil—ABCG2—endometrium—cervical cancer	0.00149	0.00571	CbGeAlD
Verapamil—CYP1A2—renal system—cervical cancer	0.00148	0.00568	CbGeAlD
Verapamil—CACNA1D—lymph node—cervical cancer	0.00147	0.00565	CbGeAlD
Verapamil—ABCG2—mammalian vulva—cervical cancer	0.00144	0.00552	CbGeAlD
Verapamil—CYP3A5—renal system—cervical cancer	0.00143	0.00548	CbGeAlD
Verapamil—CYP2B6—renal system—cervical cancer	0.00142	0.00545	CbGeAlD
Verapamil—KCNH2—female reproductive system—cervical cancer	0.00138	0.00531	CbGeAlD
Verapamil—ABCG2—uterus—cervical cancer	0.00137	0.00526	CbGeAlD
Verapamil—CACNA1C—lymph node—cervical cancer	0.00136	0.00522	CbGeAlD
Verapamil—ABCC1—female gonad—cervical cancer	0.00135	0.0052	CbGeAlD
Verapamil—ABCC1—vagina—cervical cancer	0.00134	0.00516	CbGeAlD
Verapamil—CYP2C19—vagina—cervical cancer	0.00131	0.00504	CbGeAlD
Verapamil—SLC22A5—female reproductive system—cervical cancer	0.00131	0.00502	CbGeAlD
Verapamil—CYP2C8—female reproductive system—cervical cancer	0.00127	0.00486	CbGeAlD
Verapamil—KCNH2—female gonad—cervical cancer	0.00126	0.00484	CbGeAlD
Verapamil—KCNH2—vagina—cervical cancer	0.00125	0.00481	CbGeAlD
Verapamil—ABCC3—lymph node—cervical cancer	0.00124	0.00475	CbGeAlD
Verapamil—ABCC10—lymph node—cervical cancer	0.00123	0.00472	CbGeAlD
Verapamil—SLC22A5—female gonad—cervical cancer	0.00119	0.00457	CbGeAlD
Verapamil—SLC22A5—vagina—cervical cancer	0.00118	0.00454	CbGeAlD
Verapamil—SLC22A4—lymph node—cervical cancer	0.00116	0.00444	CbGeAlD
Verapamil—CYP2C8—vagina—cervical cancer	0.00115	0.0044	CbGeAlD
Verapamil—CYP2B6—female reproductive system—cervical cancer	0.00114	0.00436	CbGeAlD
Verapamil—CYP2C9—female reproductive system—cervical cancer	0.00112	0.00432	CbGeAlD
Verapamil—ABCG2—female gonad—cervical cancer	0.00112	0.0043	CbGeAlD
Verapamil—ABCG2—vagina—cervical cancer	0.00111	0.00428	CbGeAlD
Verapamil—CYP3A4—renal system—cervical cancer	0.00107	0.00411	CbGeAlD
Verapamil—CYP2D6—renal system—cervical cancer	0.00105	0.00405	CbGeAlD
Verapamil—CYP3A5—female gonad—cervical cancer	0.00104	0.00399	CbGeAlD
Verapamil—CYP3A5—vagina—cervical cancer	0.00103	0.00397	CbGeAlD
Verapamil—CYP2B6—vagina—cervical cancer	0.00103	0.00394	CbGeAlD
Verapamil—ABCC4—lymph node—cervical cancer	0.00102	0.00392	CbGeAlD
Verapamil—ABCC2—lymph node—cervical cancer	0.000988	0.00379	CbGeAlD
Verapamil—ABCC1—lymph node—cervical cancer	0.00087	0.00334	CbGeAlD
Verapamil—CYP3A4—female reproductive system—cervical cancer	0.000858	0.00329	CbGeAlD
Verapamil—CYP2D6—female reproductive system—cervical cancer	0.000844	0.00324	CbGeAlD
Verapamil—ABCB1—epithelium—cervical cancer	0.000817	0.00314	CbGeAlD
Verapamil—ABCB1—uterine cervix—cervical cancer	0.00081	0.00311	CbGeAlD
Verapamil—KCNH2—lymph node—cervical cancer	0.00081	0.00311	CbGeAlD
Verapamil—ABCB1—decidua—cervical cancer	0.000772	0.00296	CbGeAlD
Verapamil—CYP2D6—female gonad—cervical cancer	0.000768	0.00295	CbGeAlD
Verapamil—SLC22A5—lymph node—cervical cancer	0.000765	0.00294	CbGeAlD
Verapamil—ABCB1—renal system—cervical cancer	0.000758	0.00291	CbGeAlD
Verapamil—ABCB1—endometrium—cervical cancer	0.000733	0.00281	CbGeAlD
Verapamil—ABCG2—lymph node—cervical cancer	0.00072	0.00277	CbGeAlD
Verapamil—ABCB1—mammalian vulva—cervical cancer	0.000709	0.00272	CbGeAlD
Verapamil—ABCB1—uterus—cervical cancer	0.000675	0.00259	CbGeAlD
Verapamil—ABCB1—female reproductive system—cervical cancer	0.000607	0.00233	CbGeAlD
Verapamil—ABCB1—female gonad—cervical cancer	0.000552	0.00212	CbGeAlD
Verapamil—ABCB1—vagina—cervical cancer	0.000549	0.00211	CbGeAlD
Verapamil—ABCB11—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000494	0.0277	CbGpPWpGaD
Verapamil—CACNA1A—Type II diabetes mellitus—MTOR—cervical cancer	0.000481	0.027	CbGpPWpGaD
Verapamil—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000473	0.0265	CbGpPWpGaD
Verapamil—CYP2C18—Tryptophan metabolism—UBE3A—cervical cancer	0.000469	0.0263	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—INSM1—cervical cancer	0.000451	0.0253	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—INSM1—cervical cancer	0.000424	0.0238	CbGpPWpGaD
Verapamil—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000375	0.021	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—INSM1—cervical cancer	0.000361	0.0202	CbGpPWpGaD
Verapamil—ABCB1—lymph node—cervical cancer	0.000355	0.00136	CbGeAlD
Verapamil—CACNB1—Developmental Biology—INSM1—cervical cancer	0.000351	0.0197	CbGpPWpGaD
Verapamil—CACNA1F—Alzheimers Disease—CASP8—cervical cancer	0.000351	0.0197	CbGpPWpGaD
Verapamil—ABCC3—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000331	0.0185	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—INSM1—cervical cancer	0.000313	0.0175	CbGpPWpGaD
Verapamil—ABCC4—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000311	0.0174	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—INSM1—cervical cancer	0.000303	0.017	CbGpPWpGaD
Verapamil—CACNA1F—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	0.00027	0.0151	CbGpPWpGaD
Verapamil—CACNA1F—Alzheimers Disease—CASP3—cervical cancer	0.000266	0.0149	CbGpPWpGaD
Verapamil—KCNJ11—Type II diabetes mellitus—MTOR—cervical cancer	0.000264	0.0148	CbGpPWpGaD
Verapamil—Respiratory failure—Topotecan—cervical cancer	0.000258	0.0679	CcSEcCtD
Verapamil—CACNA1S—Developmental Biology—INSM1—cervical cancer	0.000257	0.0144	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00024	0.0134	CbGpPWpGaD
Verapamil—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000239	0.0134	CbGpPWpGaD
Verapamil—ABCC3—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000231	0.013	CbGpPWpGaD
Verapamil—Rash maculo-papular—Topotecan—cervical cancer	0.000231	0.0606	CcSEcCtD
Verapamil—ABCG2—Fluoropyrimidine Activity—SMUG1—cervical cancer	0.000228	0.0128	CbGpPWpGaD
Verapamil—ABCG2—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000226	0.0127	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—INSM1—cervical cancer	0.00022	0.0124	CbGpPWpGaD
Verapamil—ABCC4—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000217	0.0122	CbGpPWpGaD
Verapamil—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	0.000216	0.0121	CbGpPWpGaD
Verapamil—ABCC4—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.000209	0.0117	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—INSM1—cervical cancer	0.000209	0.0117	CbGpPWpGaD
Verapamil—CACNB4—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	0.00019	0.0107	CbGpPWpGaD
Verapamil—Lethargy—Topotecan—cervical cancer	0.000188	0.0494	CcSEcCtD
Verapamil—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—cervical cancer	0.000186	0.0104	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—INSM1—cervical cancer	0.000185	0.0104	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—INSM1—cervical cancer	0.000183	0.0103	CbGpPWpGaD
Verapamil—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000176	0.00989	CbGpPWpGaD
Verapamil—Cardiac arrest—Topotecan—cervical cancer	0.000175	0.046	CcSEcCtD
Verapamil—CACNA1F—Alzheimers Disease—TP53—cervical cancer	0.00017	0.00955	CbGpPWpGaD
Verapamil—Cramp muscle—Topotecan—cervical cancer	0.000166	0.0436	CcSEcCtD
Verapamil—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000165	0.00924	CbGpPWpGaD
Verapamil—ABCG2—Fluoropyrimidine Activity—MTHFR—cervical cancer	0.000159	0.00894	CbGpPWpGaD
Verapamil—SCN5A—Cardiac Progenitor Differentiation—NOTCH1—cervical cancer	0.000153	0.0086	CbGpPWpGaD
Verapamil—CACNB3—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	0.000152	0.00852	CbGpPWpGaD
Verapamil—CACNB1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	0.000148	0.00829	CbGpPWpGaD
Verapamil—CACNA1S—Alzheimers Disease—CASP8—cervical cancer	0.000141	0.0079	CbGpPWpGaD
Verapamil—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000141	0.0079	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—UBE3A—cervical cancer	0.000138	0.00773	CbGpPWpGaD
Verapamil—Sweating—Topotecan—cervical cancer	0.000136	0.0358	CcSEcCtD
Verapamil—CYP1A2—Tryptophan metabolism—UBE3A—cervical cancer	0.000136	0.00761	CbGpPWpGaD
Verapamil—Rhinitis—Topotecan—cervical cancer	0.000128	0.0336	CcSEcCtD
Verapamil—Hypoaesthesia—Topotecan—cervical cancer	0.000127	0.0333	CcSEcCtD
Verapamil—Pharyngitis—Topotecan—cervical cancer	0.000126	0.0332	CcSEcCtD
Verapamil—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.000124	0.00694	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—SERPIND1—cervical cancer	0.000124	0.00693	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—GP6—cervical cancer	0.000124	0.00693	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.000122	0.00684	CbGpPWpGaD
Verapamil—CACNA1D—Alzheimers Disease—CASP8—cervical cancer	0.000114	0.00641	CbGpPWpGaD
Verapamil—Alopecia—Topotecan—cervical cancer	0.000113	0.0296	CcSEcCtD
Verapamil—CACNA1H—Corticotropin-releasing hormone—CASP3—cervical cancer	0.000111	0.00623	CbGpPWpGaD
Verapamil—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.000109	0.00609	CbGpPWpGaD
Verapamil—CACNA1S—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	0.000108	0.00607	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—GP5—cervical cancer	0.000108	0.00605	CbGpPWpGaD
Verapamil—CACNA1H—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.000107	0.00601	CbGpPWpGaD
Verapamil—Muscle spasms—Topotecan—cervical cancer	0.000107	0.028	CcSEcCtD
Verapamil—CACNA1S—Alzheimers Disease—CASP3—cervical cancer	0.000107	0.00598	CbGpPWpGaD
Verapamil—CYP3A4—Tryptophan metabolism—UBE3A—cervical cancer	0.000105	0.00587	CbGpPWpGaD
Verapamil—Angioedema—Topotecan—cervical cancer	0.000101	0.0266	CcSEcCtD
Verapamil—CACNA1C—Alzheimers Disease—CASP8—cervical cancer	0.0001	0.00563	CbGpPWpGaD
Verapamil—Arthralgia—Topotecan—cervical cancer	9.45e-05	0.0248	CcSEcCtD
Verapamil—Chest pain—Topotecan—cervical cancer	9.45e-05	0.0248	CcSEcCtD
Verapamil—Myalgia—Topotecan—cervical cancer	9.45e-05	0.0248	CcSEcCtD
Verapamil—Discomfort—Topotecan—cervical cancer	9.33e-05	0.0245	CcSEcCtD
Verapamil—CACNB2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	9.28e-05	0.0052	CbGpPWpGaD
Verapamil—ABCG2—HIF-1-alpha transcription factor network—TERT—cervical cancer	9.13e-05	0.00512	CbGpPWpGaD
Verapamil—Anaphylactic shock—Topotecan—cervical cancer	9.05e-05	0.0238	CcSEcCtD
Verapamil—Infection—Topotecan—cervical cancer	9e-05	0.0236	CcSEcCtD
Verapamil—CACNA1D—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	8.79e-05	0.00493	CbGpPWpGaD
Verapamil—ABCC3—Fluoropyrimidine Activity—TP53—cervical cancer	8.78e-05	0.00492	CbGpPWpGaD
Verapamil—Hyperhidrosis—Topotecan—cervical cancer	8.75e-05	0.023	CcSEcCtD
Verapamil—CACNA1D—Alzheimers Disease—CASP3—cervical cancer	8.65e-05	0.00485	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—HES1—cervical cancer	8.57e-05	0.0048	CbGpPWpGaD
Verapamil—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	8.34e-05	0.00468	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—HES1—cervical cancer	8.31e-05	0.00466	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—HES1—cervical cancer	8.3e-05	0.00465	CbGpPWpGaD
Verapamil—ABCC4—Fluoropyrimidine Activity—TP53—cervical cancer	8.26e-05	0.00463	CbGpPWpGaD
Verapamil—Musculoskeletal discomfort—Topotecan—cervical cancer	8.25e-05	0.0217	CcSEcCtD
Verapamil—Paraesthesia—Topotecan—cervical cancer	8.13e-05	0.0214	CcSEcCtD
Verapamil—Dyspnoea—Topotecan—cervical cancer	8.07e-05	0.0212	CcSEcCtD
Verapamil—Dyspepsia—Topotecan—cervical cancer	7.97e-05	0.021	CcSEcCtD
Verapamil—Fatigue—Topotecan—cervical cancer	7.81e-05	0.0205	CcSEcCtD
Verapamil—CACNA1I—Developmental Biology—HES1—cervical cancer	7.8e-05	0.00437	CbGpPWpGaD
Verapamil—Constipation—Topotecan—cervical cancer	7.74e-05	0.0204	CcSEcCtD
Verapamil—Pain—Topotecan—cervical cancer	7.74e-05	0.0204	CcSEcCtD
Verapamil—CACNA1C—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—cervical cancer	7.72e-05	0.00433	CbGpPWpGaD
Verapamil—CACNA1C—Alzheimers Disease—CASP3—cervical cancer	7.6e-05	0.00426	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—HES1—cervical cancer	7.48e-05	0.00419	CbGpPWpGaD
Verapamil—Feeling abnormal—Topotecan—cervical cancer	7.46e-05	0.0196	CcSEcCtD
Verapamil—CYP1A2—Estrogen Receptor Pathway—STAT3—cervical cancer	7.21e-05	0.00405	CbGpPWpGaD
Verapamil—Urticaria—Topotecan—cervical cancer	7.19e-05	0.0189	CcSEcCtD
Verapamil—CACNA1S—Alzheimers Disease—TP53—cervical cancer	6.83e-05	0.00383	CbGpPWpGaD
Verapamil—Hypersensitivity—Topotecan—cervical cancer	6.67e-05	0.0175	CcSEcCtD
Verapamil—CACNB3—Developmental Biology—HES1—cervical cancer	6.63e-05	0.00372	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	6.58e-05	0.00369	CbGpPWpGaD
Verapamil—Asthenia—Topotecan—cervical cancer	6.5e-05	0.0171	CcSEcCtD
Verapamil—CACNB1—Developmental Biology—HES1—cervical cancer	6.45e-05	0.00362	CbGpPWpGaD
Verapamil—Pruritus—Topotecan—cervical cancer	6.41e-05	0.0168	CcSEcCtD
Verapamil—CACNB4—Developmental Biology—NOTCH1—cervical cancer	6.26e-05	0.00351	CbGpPWpGaD
Verapamil—Diarrhoea—Topotecan—cervical cancer	6.2e-05	0.0163	CcSEcCtD
Verapamil—CACNA1A—Metabolism—CA9—cervical cancer	6.08e-05	0.00341	CbGpPWpGaD
Verapamil—ABCG2—Fluoropyrimidine Activity—TP53—cervical cancer	6.05e-05	0.00339	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—cervical cancer	6e-05	0.00337	CbGpPWpGaD
Verapamil—Dizziness—Topotecan—cervical cancer	5.99e-05	0.0157	CcSEcCtD
Verapamil—CACNA1I—Developmental Biology—NOTCH1—cervical cancer	5.89e-05	0.0033	CbGpPWpGaD
Verapamil—Vomiting—Topotecan—cervical cancer	5.76e-05	0.0151	CcSEcCtD
Verapamil—CACNA1G—Developmental Biology—HES1—cervical cancer	5.75e-05	0.00322	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—CA9—cervical cancer	5.71e-05	0.0032	CbGpPWpGaD
Verapamil—Rash—Topotecan—cervical cancer	5.71e-05	0.015	CcSEcCtD
Verapamil—Dermatitis—Topotecan—cervical cancer	5.7e-05	0.015	CcSEcCtD
Verapamil—Headache—Topotecan—cervical cancer	5.67e-05	0.0149	CcSEcCtD
Verapamil—CACNA1H—Developmental Biology—HES1—cervical cancer	5.57e-05	0.00312	CbGpPWpGaD
Verapamil—CACNA1D—Alzheimers Disease—TP53—cervical cancer	5.55e-05	0.00311	CbGpPWpGaD
Verapamil—Nausea—Topotecan—cervical cancer	5.38e-05	0.0141	CcSEcCtD
Verapamil—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	5.14e-05	0.00288	CbGpPWpGaD
Verapamil—SCN5A—L1CAM interactions—EGFR—cervical cancer	5.02e-05	0.00282	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—NOTCH1—cervical cancer	5.01e-05	0.00281	CbGpPWpGaD
Verapamil—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	4.94e-05	0.00277	CbGpPWpGaD
Verapamil—CACNA1C—Alzheimers Disease—TP53—cervical cancer	4.87e-05	0.00273	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—NOTCH1—cervical cancer	4.87e-05	0.00273	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—HES1—cervical cancer	4.73e-05	0.00265	CbGpPWpGaD
Verapamil—CACNB4—Axon guidance—EGFR—cervical cancer	4.62e-05	0.00259	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—CASP3—cervical cancer	4.46e-05	0.0025	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	4.43e-05	0.00249	CbGpPWpGaD
Verapamil—CACNA1I—Axon guidance—EGFR—cervical cancer	4.34e-05	0.00244	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—NOTCH1—cervical cancer	4.34e-05	0.00243	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—CASP3—cervical cancer	4.32e-05	0.00242	CbGpPWpGaD
Verapamil—SCN5A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	4.3e-05	0.00241	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—NOTCH1—cervical cancer	4.2e-05	0.00236	CbGpPWpGaD
Verapamil—KCNH2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	4.17e-05	0.00234	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—CTNNB1—cervical cancer	4.16e-05	0.00233	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—HES1—cervical cancer	4.05e-05	0.00227	CbGpPWpGaD
Verapamil—ABCC4—Ectoderm Differentiation—CTNNB1—cervical cancer	3.95e-05	0.00222	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—CTNNB1—cervical cancer	3.91e-05	0.00219	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—CASP3—cervical cancer	3.89e-05	0.00218	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—HES1—cervical cancer	3.84e-05	0.00215	CbGpPWpGaD
Verapamil—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	3.75e-05	0.0021	CbGpPWpGaD
Verapamil—CACNB3—Axon guidance—EGFR—cervical cancer	3.69e-05	0.00207	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—STAT3—cervical cancer	3.63e-05	0.00203	CbGpPWpGaD
Verapamil—CACNB1—Axon guidance—EGFR—cervical cancer	3.59e-05	0.00201	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—NOTCH1—cervical cancer	3.57e-05	0.002	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—CA9—cervical cancer	3.49e-05	0.00196	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—STAT3—cervical cancer	3.41e-05	0.00191	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—HES1—cervical cancer	3.41e-05	0.00191	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—HES1—cervical cancer	3.37e-05	0.00189	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—CASP8—cervical cancer	3.36e-05	0.00188	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—CA9—cervical cancer	3.33e-05	0.00187	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—CTNNB1—cervical cancer	3.33e-05	0.00187	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—CA9—cervical cancer	3.3e-05	0.00185	CbGpPWpGaD
Verapamil—CACNB4—Developmental Biology—EGFR—cervical cancer	3.3e-05	0.00185	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—CTNNB1—cervical cancer	3.24e-05	0.00181	CbGpPWpGaD
Verapamil—CACNA1G—Axon guidance—EGFR—cervical cancer	3.2e-05	0.0018	CbGpPWpGaD
Verapamil—CACNA1H—Axon guidance—EGFR—cervical cancer	3.1e-05	0.00174	CbGpPWpGaD
Verapamil—CACNA1I—Developmental Biology—EGFR—cervical cancer	3.1e-05	0.00174	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—NOTCH1—cervical cancer	3.06e-05	0.00172	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—CA9—cervical cancer	2.9e-05	0.00163	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—STAT3—cervical cancer	2.9e-05	0.00163	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—NOTCH1—cervical cancer	2.9e-05	0.00162	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—CTNNB1—cervical cancer	2.88e-05	0.00162	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—STAT3—cervical cancer	2.82e-05	0.00158	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—CTNNB1—cervical cancer	2.79e-05	0.00157	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—CA9—cervical cancer	2.71e-05	0.00152	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—CA9—cervical cancer	2.67e-05	0.0015	CbGpPWpGaD
Verapamil—CACNB3—Developmental Biology—EGFR—cervical cancer	2.64e-05	0.00148	CbGpPWpGaD
Verapamil—CACNA1S—Axon guidance—EGFR—cervical cancer	2.63e-05	0.00148	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—CA9—cervical cancer	2.6e-05	0.00146	CbGpPWpGaD
Verapamil—ABCC1—Disease—WNT2—cervical cancer	2.58e-05	0.00145	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—NOTCH1—cervical cancer	2.57e-05	0.00144	CbGpPWpGaD
Verapamil—CACNB1—Developmental Biology—EGFR—cervical cancer	2.56e-05	0.00144	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—NOTCH1—cervical cancer	2.55e-05	0.00143	CbGpPWpGaD
Verapamil—ABCB1—Allograft Rejection—CASP3—cervical cancer	2.54e-05	0.00142	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—STAT3—cervical cancer	2.51e-05	0.00141	CbGpPWpGaD
Verapamil—CACNA1A—Metabolism—MTHFR—cervical cancer	2.47e-05	0.00138	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—STAT3—cervical cancer	2.43e-05	0.00137	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	2.39e-05	0.00134	CbGpPWpGaD
Verapamil—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	2.39e-05	0.00134	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—CTNNB1—cervical cancer	2.37e-05	0.00133	CbGpPWpGaD
Verapamil—CACNB3—Metabolism—MTHFR—cervical cancer	2.32e-05	0.0013	CbGpPWpGaD
Verapamil—CACNA1G—Developmental Biology—EGFR—cervical cancer	2.28e-05	0.00128	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—CA9—cervical cancer	2.27e-05	0.00127	CbGpPWpGaD
Verapamil—CACNB2—Axon guidance—EGFR—cervical cancer	2.26e-05	0.00126	CbGpPWpGaD
Verapamil—CACNA1H—Developmental Biology—EGFR—cervical cancer	2.21e-05	0.00124	CbGpPWpGaD
Verapamil—CACNA1D—Axon guidance—EGFR—cervical cancer	2.14e-05	0.0012	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—STAT3—cervical cancer	2.07e-05	0.00116	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—CA9—cervical cancer	2.04e-05	0.00114	CbGpPWpGaD
Verapamil—SLC6A4—Circadian rythm related genes—TP53—cervical cancer	2.04e-05	0.00114	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—CTNNB1—cervical cancer	2.03e-05	0.00114	CbGpPWpGaD
Verapamil—ABCC1—Disease—WNT5A—cervical cancer	1.95e-05	0.0011	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—CA9—cervical cancer	1.94e-05	0.00109	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—CTNNB1—cervical cancer	1.92e-05	0.00108	CbGpPWpGaD
Verapamil—SCN5A—Axon guidance—EGFR—cervical cancer	1.9e-05	0.00106	CbGpPWpGaD
Verapamil—CACNA1S—Developmental Biology—EGFR—cervical cancer	1.88e-05	0.00105	CbGpPWpGaD
Verapamil—CACNA1C—Axon guidance—EGFR—cervical cancer	1.88e-05	0.00105	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—CA9—cervical cancer	1.79e-05	0.00101	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—CA9—cervical cancer	1.78e-05	0.000997	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—STAT3—cervical cancer	1.77e-05	0.000993	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—CTNNB1—cervical cancer	1.71e-05	0.000958	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—CTNNB1—cervical cancer	1.69e-05	0.000948	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—STAT3—cervical cancer	1.68e-05	0.000941	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	1.66e-05	0.000929	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—CA9—cervical cancer	1.65e-05	0.000928	CbGpPWpGaD
Verapamil—CACNB2—Developmental Biology—EGFR—cervical cancer	1.61e-05	0.000903	CbGpPWpGaD
Verapamil—CACNA1D—Developmental Biology—EGFR—cervical cancer	1.52e-05	0.000855	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—STAT3—cervical cancer	1.49e-05	0.000835	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—STAT3—cervical cancer	1.47e-05	0.000826	CbGpPWpGaD
Verapamil—CACNB2—Metabolism—MTHFR—cervical cancer	1.42e-05	0.000794	CbGpPWpGaD
Verapamil—SCN5A—Developmental Biology—EGFR—cervical cancer	1.35e-05	0.000759	CbGpPWpGaD
Verapamil—KCNJ11—Metabolism—MTHFR—cervical cancer	1.35e-05	0.000757	CbGpPWpGaD
Verapamil—CACNA1D—Metabolism—MTHFR—cervical cancer	1.34e-05	0.000752	CbGpPWpGaD
Verapamil—CACNA1C—Developmental Biology—EGFR—cervical cancer	1.34e-05	0.000751	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—CA9—cervical cancer	1.31e-05	0.000737	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—CA9—cervical cancer	1.29e-05	0.000721	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	1.25e-05	0.000703	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	1.21e-05	0.000677	CbGpPWpGaD
Verapamil—CACNA1C—Metabolism—MTHFR—cervical cancer	1.18e-05	0.000661	CbGpPWpGaD
Verapamil—ABCC1—Disease—HES1—cervical cancer	1.12e-05	0.00063	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—CA9—cervical cancer	1.11e-05	0.000624	CbGpPWpGaD
Verapamil—ABCB11—Metabolism—MTHFR—cervical cancer	1.1e-05	0.000617	CbGpPWpGaD
Verapamil—CYP2C18—Metabolism—MTHFR—cervical cancer	1.09e-05	0.000609	CbGpPWpGaD
Verapamil—ABCC3—Metabolism—MTHFR—cervical cancer	1.06e-05	0.000592	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—CA9—cervical cancer	9.94e-06	0.000557	CbGpPWpGaD
Verapamil—ABCC1—Disease—MTHFR—cervical cancer	9.88e-06	0.000554	CbGpPWpGaD
Verapamil—ABCC1—Disease—TERT—cervical cancer	9.85e-06	0.000552	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—CA9—cervical cancer	9.7e-06	0.000544	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	9.57e-06	0.000537	CbGpPWpGaD
Verapamil—ABCC4—Hemostasis—TP53—cervical cancer	9.29e-06	0.000521	CbGpPWpGaD
Verapamil—SLCO1A2—Metabolism—MTHFR—cervical cancer	9.19e-06	0.000515	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—CA9—cervical cancer	9.14e-06	0.000512	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—CA9—cervical cancer	9.06e-06	0.000508	CbGpPWpGaD
Verapamil—ABCC1—Disease—FGFR3—cervical cancer	9.04e-06	0.000507	CbGpPWpGaD
Verapamil—ABCC1—Disease—NOTCH1—cervical cancer	8.49e-06	0.000476	CbGpPWpGaD
Verapamil—ABCC1—Metabolism—MTHFR—cervical cancer	8.27e-06	0.000464	CbGpPWpGaD
Verapamil—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	8.03e-06	0.000451	CbGpPWpGaD
Verapamil—SLCO1B1—Metabolism—MTHFR—cervical cancer	7.86e-06	0.000441	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—CA9—cervical cancer	7.74e-06	0.000434	CbGpPWpGaD
Verapamil—ABCG2—Metabolism—MTHFR—cervical cancer	7.28e-06	0.000408	CbGpPWpGaD
Verapamil—CYP3A7—Metabolism—MTHFR—cervical cancer	7.21e-06	0.000405	CbGpPWpGaD
Verapamil—SLC22A1—Metabolism—MTHFR—cervical cancer	6.71e-06	0.000377	CbGpPWpGaD
Verapamil—ABCC1—Disease—MTOR—cervical cancer	6.36e-06	0.000357	CbGpPWpGaD
Verapamil—ABCC1—Disease—CD4—cervical cancer	6.35e-06	0.000356	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—CA9—cervical cancer	5.97e-06	0.000335	CbGpPWpGaD
Verapamil—ABCC1—Disease—CTNNB1—cervical cancer	5.64e-06	0.000316	CbGpPWpGaD
Verapamil—CYP2B6—Metabolism—MTHFR—cervical cancer	5.34e-06	0.000299	CbGpPWpGaD
Verapamil—CYP3A5—Metabolism—MTHFR—cervical cancer	5.22e-06	0.000292	CbGpPWpGaD
Verapamil—ABCC1—Disease—STAT3—cervical cancer	4.91e-06	0.000276	CbGpPWpGaD
Verapamil—CYP2C8—Metabolism—MTHFR—cervical cancer	4.52e-06	0.000253	CbGpPWpGaD
Verapamil—ABCC1—Disease—EGFR—cervical cancer	4.47e-06	0.00025	CbGpPWpGaD
Verapamil—CYP2C19—Metabolism—MTHFR—cervical cancer	4.03e-06	0.000226	CbGpPWpGaD
Verapamil—ABCB1—Metabolism—MTHFR—cervical cancer	3.94e-06	0.000221	CbGpPWpGaD
Verapamil—CYP2D6—Metabolism—MTHFR—cervical cancer	3.71e-06	0.000208	CbGpPWpGaD
Verapamil—CYP2C9—Metabolism—MTHFR—cervical cancer	3.68e-06	0.000206	CbGpPWpGaD
Verapamil—CYP1A2—Metabolism—MTHFR—cervical cancer	3.14e-06	0.000176	CbGpPWpGaD
Verapamil—CYP3A4—Metabolism—MTHFR—cervical cancer	2.42e-06	0.000136	CbGpPWpGaD
